跳到正文
原文
Nature 健康护理主题·· 16 天前AI 评分9

tocilizumab 与 sarilumab 治疗住院新冠成人患者的靶向试验模拟结果更正

Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland

AI 导读

作者更正了 Nature Communications 于 2026 年 5 月 15 日发表的文章,纠正了作者姓名的错误。该研究通过靶向试验模拟,比较了 tocilizumab 和 sarilumab 在英国和苏格兰住院新冠成人患者中的效果。

正文

Correction to: Nature Communications https://doi.org/10.1038/s41467-026-73134-9, published online 15 May 2026

In this article the author’s name Aziz Sheikh was written as Sir Aziz Sheikh. The original article has been updated.

Author information

Author notes

  1. These authors contributed equally: Bang Zheng, Amanj Kurdi, Alain Amstutz.

Authors and Affiliations

  1. Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China

    Bang Zheng

  2. Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China

    Bang Zheng

  3. Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK

    Bang Zheng, Emily Herrett, Qing Wen, Viyaasan Mahalingasivam & Laurie Tomlinson

  4. Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China

    Bang Zheng

  5. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK

    Amanj Kurdi

  6. Public Health Scotland, Edinburgh, UK

    Amanj Kurdi

  7. College of Pharmacy, Hawler Medical University, Erbil, Iraq

    Amanj Kurdi

  8. Al-Kitab University, Kirkuk, Iraq

    Amanj Kurdi

  9. Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa

    Amanj Kurdi

  10. Electronic Health Records Group, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK

    Alain Amstutz

  11. Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway

    Alain Amstutz

  12. Division Clinical Epidemiology, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland

    Alain Amstutz

  13. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK

    Amelia Green, Rebecca Smith, Brian MacKenna, Amir Mehrkar, Seb Bacon, Ben Goldacre & Aziz Sheikh

  14. Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK

    John Tazare

  15. Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK

    Qing Wen

  16. Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK

    Chris Robertson

  17. Usher Institute, University of Edinburgh, Edinburgh, UK

    Aziz Sheikh

Authors

  1. Bang Zheng
  2. Amanj Kurdi
  3. Alain Amstutz
  4. Amelia Green
  5. Emily Herrett
  6. John Tazare
  7. Qing Wen
  8. Viyaasan Mahalingasivam
  9. Rebecca Smith
  10. Brian MacKenna
  11. Amir Mehrkar
  12. Seb Bacon
  13. Ben Goldacre
  14. Chris Robertson
  15. Aziz Sheikh
  16. Laurie Tomlinson

Consortia

On behalf of The OpenSAFELY Collaborative

  • Bang Zheng
  • , Amelia Green
  • , Emily Herrett
  • , John Tazare
  • , Viyaasan Mahalingasivam
  • , Rebecca Smith
  • , Brian MacKenna
  • , Amir Mehrkar
  • , Seb Bacon
  • , Ben Goldacre
  •  & Laurie Tomlinson

Corresponding authors

Correspondence to Aziz Sheikh or Laurie Tomlinson.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zheng, B., Kurdi, A., Amstutz, A. et al. Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland. Nat Commun 17, 11414 (2026). https://doi.org/10.1038/s41467-026-78874-2

Download citation

  • Published: 04 November 2026

  • Version of record: 04 November 2026

  • DOI: https://doi.org/10.1038/s41467-026-78874-2

来源:Nature 健康护理主题 · nature.com